Agile Therapeutics Inc's ability to collect accounts receivable sequentially worsen to 4.85, indicating more challenging environment then in the first quarter 2024, but still, it is a far cry from any concerns. Agile Therapeutics Inc's Accounts Receivable average collection period in the Jun 30 2024 quarter, has increased to 75 days, from 74 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 33 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 388, from overall ranking in the first quarter 2024 at 2696.

What is Receivable Turnover Ratio?
What is Agile Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AGRX Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	2 %	54.11 %	0.44 %	-5.12 %	113.75 %
Y / Y Revenue Change	-2.23 %	32.07 %	-14.37 %	106.03 %	144.4 %
Receivable Turnover Ratio (TTM)	4.85	4.9	5.14	5.3	4.36
AGRX's Total Ranking	# 388	# 2696	# 300	# 2630	# 837
Accounts Receivable average collection period days	75	74	71	69	84
Seq. Receivable Change	-5.46 %	41.89 %	-3.66 %	-21.07 %	42.84 %
Seq. Revenue Change	0.87 %	47.21 %	-44.69 %	19.03 %	36.27 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 11
Healthcare Sector	# 34
Overall Market	# 388

Receivable Turnover Ratio Statistics
High	Average	Low
1.71	0.78	0.06
(Mar 31 2024)		(Sep 30 2021)

AGRX Company Profile • Back to AGRX Efficiency Comparisons • Compare AGRX Receivables Turnover Ratio to its Competitors

Financial Statements
Agile Therapeutics Inc's Accounts Receivable	$ 5 Millions	Visit AGRX's Balance sheet
Agile Therapeutics Inc's Sales TTM	$ 20 Millions	Visit AGRX's Income Statement
Sources of AGRX's Revenues		Visit AGRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AGRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AGRX's Growth Rates	AGRX's Roa	AGRX's Inventory Turnover Ratio	AGRX's Dividend Comparisons
AGRX's Profitability Ratios	AGRX's Roi	AGRX's Asset Turnover Ratio	AGRX's Dividend Growth
AGRX's Valuation Ratios	AGRX's Roe	AGRX's Financial Strength Ratios	AGRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Petvivo Holdings Inc	11.71	$ 0.975 Millions	$ 0.083 Millions
Exact Sciences Corporation	11.60	$ 2,632.090 Millions	$ 226.869 Millions
Rosecliff Acquisition Corp I	11.58	$ 22.531 Millions	$ 1.945 Millions
Integrated Biopharma Inc	11.54	$ 49.884 Millions	$ 4.323 Millions
Biocorrx Inc	11.35	$ 0.037 Millions	$ 0.003 Millions
Valion Bio Inc	11.27	$ 1.113 Millions	$ 0.099 Millions
Ispecimen inc	11.16	$ 10.507 Millions	$ 0.941 Millions
American Oncology Network Inc	11.05	$ 1,458.808 Millions	$ 131.978 Millions
Vaxart Inc	10.98	$ 13.928 Millions	$ 1.269 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	10.79	$ 3.106 Millions	$ 0.288 Millions
Sunshine Biopharma Inc	10.71	$ 30.482 Millions	$ 2.847 Millions
Lipella Pharmaceuticals Inc	10.70	$ 0.507 Millions	$ 0.047 Millions
National Healthcare Corp	10.64	$ 1,187.233 Millions	$ 111.550 Millions
Sunlink Health Systems Inc	10.57	$ 32.442 Millions	$ 3.069 Millions
Tandem Diabetes Care Inc	10.54	$ 795.884 Millions	$ 75.498 Millions
Bionexus Gene Lab Corp	10.41	$ 9.183 Millions	$ 0.882 Millions
Reflect Scientific Inc	10.29	$ 1.734 Millions	$ 0.168 Millions
Procyon Corporation	10.28	$ 4.984 Millions	$ 0.485 Millions
Strata Critical Medical Inc	10.22	$ 238.379 Millions	$ 23.329 Millions
Option Care Health Inc	10.18	$ 4,589.168 Millions	$ 450.641 Millions
Tonix Pharmaceuticals Holding Corp	10.17	$ 12.458 Millions	$ 1.225 Millions
Lensar Inc	10.16	$ 45.124 Millions	$ 4.441 Millions
Immucell Corporation	10.15	$ 21.889 Millions	$ 2.156 Millions
Addus Homecare Corp	9.88	$ 1,112.632 Millions	$ 112.633 Millions
Inogen Inc	9.80	$ 326.653 Millions	$ 33.320 Millions
Surmodics Inc	9.77	$ 120.821 Millions	$ 12.370 Millions
Clearpoint Neuro Inc	9.66	$ 28.069 Millions	$ 2.905 Millions
Quidelortho Corp	9.64	$ 2,834.600 Millions	$ 293.925 Millions
Semler Scientific inc	9.61	$ 61.741 Millions	$ 6.423 Millions
Vaso Corporation	9.60	$ 80.554 Millions	$ 8.395 Millions

Date modified: 2026-09-26T07:14:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.